Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | December 02, 2022 05:32pm

Gainers

  • Lannett (NYSE:LCI) stock moved upwards by 14.5% to $0.71 during Friday's after-market session. The market value of their outstanding shares is at $29.7 million.
  • Owlet (NYSE:OWLT) shares rose 12.19% to $0.87. The market value of their outstanding shares is at $99.6 million.
  • Chembio Diagnostics (NASDAQ:CEMI) shares increased by 7.76% to $0.32. The market value of their outstanding shares is at $11.6 million.
  • Pulse Biosciences (NASDAQ:PLSE) stock increased by 6.79% to $2.2. The company's market cap stands at $81.8 million.
  • Neuronetics (NASDAQ:STIM) stock moved upwards by 6.62% to $6.6. The company's market cap stands at $179.6 million.
  • Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 5.4% to $0.39. The company's market cap stands at $15.6 million.

Losers

  • Gelesis Holdings (NYSE:GLS) stock fell 16.7% to $0.4 during Friday's after-market session. The company's market cap stands at $29.2 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 9.43% to $1.25. The company's market cap stands at $84.5 million.
  • GlycoMimetics (NASDAQ:GLYC) shares fell 6.12% to $2.15. The market value of their outstanding shares is at $112.7 million.
  • Conformis (NASDAQ:CFMS) stock declined by 5.66% to $3.17. The company's market cap stands at $23.8 million.
  • Verrica Pharmaceuticals (NASDAQ:VRCA) stock declined by 5.06% to $3.19. The market value of their outstanding shares is at $131.0 million.
  • Surface Oncology (NASDAQ:SURF) shares fell 5.0% to $0.93. The market value of their outstanding shares is at $56.2 million.
    See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATHE CEMI CFMS GLS GLYC LCI NRXP OWLT PLSE STIM SURF VRCA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist